title: Friend or foe? Role of peroxisome proliferator-activated receptor-gamma in human bladder cancer.
abstract: The peroxisome proliferator-activated receptor (PPAR) family is an important group of transcription factors that regulates immune surveillance, cell proliferation, fatty acid regulation, and angiogenesis--functions which have all been implicated in the pathogenesis of bladder cancer. One particular subtype, PPARgamma, is expressed at higher levels in bladder cancer specimens than in benign urothelium, and is an attractive molecular target for the development of novel treatment strategies for bladder cancer. In this review, we summarize the data available regarding relevance of PPARgamma in bladder cancer and discuss the potential value of PPAR-targeted treatment of bladder cancer.
authors.affiliation: Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
authors.forename: Teruo
authors.initials: T
authors.lastname: Inamoto
authors.forename: Jay B
authors.initials: JB
authors.lastname: Shah
authors.forename: Ashish M
authors.initials: AM
authors.lastname: Kamat
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D017209:Apoptosis / Q000187:drug effects; D001500:BCG Vaccine / Q000008:administration & dosage / Q000627:therapeutic use; D018450:Disease Progression; D006801:Humans; D009361:Neoplasm Invasiveness; D047495:PPAR gamma / Q000819:agonists* / Q000378:metabolism*; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000494:pharmacology / Q000627:therapeutic use*; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000378:metabolism* / Q000473:pathology
chemical_list: D000276:Adjuvants, Immunologic; D000970:Antineoplastic Agents; D001500:BCG Vaccine; D047495:PPAR gamma; D045162:Thiazolidinediones; D000077154:Rosiglitazone